Australian Institute of Health and Welfare (2020) Cancer screening and COVID-19 in Australia, AIHW, Australian Government, accessed 27 November 2022.
Australian Institute of Health and Welfare. (2020). Cancer screening and COVID-19 in Australia. Retrieved from https://www.aihw.gov.au/reports/cancer-screening/cancer-screening-and-covid-19-in-australia
Cancer screening and COVID-19 in Australia. Australian Institute of Health and Welfare, 17 December 2020, https://www.aihw.gov.au/reports/cancer-screening/cancer-screening-and-covid-19-in-australia
Australian Institute of Health and Welfare. Cancer screening and COVID-19 in Australia [Internet]. Canberra: Australian Institute of Health and Welfare, 2020 [cited 2022 Nov. 27]. Available from: https://www.aihw.gov.au/reports/cancer-screening/cancer-screening-and-covid-19-in-australia
Australian Institute of Health and Welfare (AIHW) 2020, Cancer screening and COVID-19 in Australia, viewed 27 November 2022, https://www.aihw.gov.au/reports/cancer-screening/cancer-screening-and-covid-19-in-australia
Get citations as an Endnote file:
PDF | 872Kb
At the time of publication, the COVID-19 pandemic continues to be an evolving situation, posing a threat to people’s health and wellbeing in Australia and globally. The data presented here cover the period from January to September 2020, capturing the first 9 months of the disease in Australia.
Data after this period will be captured in quarterly cancer screening data that are routinely published by the AIHW.
The national data included in this report, as well as state and territory monthly data, are shown in the associated data tables.
This report uses timely data to enable useful comparisons of trends in screening tests over the initial COVID-19 period in Australia—BreastScreen data from state and territory BreastScreen registers were supplied in November 2020, and National Cervical Screening Program and National Bowel Cancer Screening Program data were extracted from the National Cancer Screening Register in November 2020. When considering timely data, it is important to note that these are sourced from live databases, which are updated over time, with later data supply likely to have a greater level of completeness.
This means that the data in this report are considered preliminary, and should be not be directly compared with data used in other AIHW cancer screening reports, where data are sourced at a different time.
To protect clients, staff and the community from the risk of COVID-19, BreastScreen services were temporarily suspended from 25 March 2020. While the suspension was lifted around a month later (in late April–early May 2020 for many services), breast screening resumed in a staged approach with longer appointments and precautionary measures to ensure the safety of women and staff. The rate at which BreastScreen services could resume was impacted by various jurisdictional social distancing and infection control guidelines and requirements. BreastScreen services remained open during Victoria's second wave.
The number of screening mammograms performed through BreastScreen Australia significantly declined in March 2020 as the COVID-19 pandemic worsened and tighter restrictions were put in place that included a suspension of all BreastScreen services from 25 March 2020.
While more than 70,000 screening mammograms were conducted in March 2020, this had fallen to just over 1,100 in April. By comparison, in April 2018, more than 74,000 screening mammograms were carried out (2018 is chosen as the comparison year instead of 2019, as BreastScreen Australia is a biennial program).
Following an easing of restrictions that included a lifting of the suspension from late April/early May 2020, the number of screening mammograms increased through May and June, and in July 2020 numbered around 3,000 more than in July 2018. In September, the number of screening mammograms increased to over 90,000, which was again greater than the number of screening mammograms in September 2018.
In summary, while there were around 145,000 fewer screening mammograms performed through BreastScreen Australia in January to June 2020 compared with January to June 2018, there were around 12,000 more screening mammograms performed through BreastScreen Australia in July to September 2020 compared with July to September 2018.
Chart: Australian Institute of Health and Welfare
Source: Australian Institute of Health and Welfare analysis of state and territory BreastScreen register data
Due to changes to the National Cervical Screening Program, the number of new Cervical Screening Tests conducted was expected to be lower in 2020 than in 2019, irrespective of the COVID-19 pandemic and subsequent restrictions. This is largely due to the program changing from 2-yearly Pap tests to 5-yearly Cervical Screening Tests (as modelled in Smith et al. 2016). This makes it inappropriate to directly compare 2020 data to 2019 data.
Data show that, as expected, there were fewer tests performed in 2020 than in 2019. The number of tests in 2019 is shown alongside 2020 to provide context of cervical screening trends that could also be expected to occur in 2020 (for example, there are typically fewer tests performed around Easter and Christmas).
The expected trend of fewer cervical screening tests in 2020 compared with 2019 due to the change from 2-yearly to 5-yearly screening is evident.
Data show a decline in the number of cervical screening tests from the second half of March 2020. The number of tests remained low throughout April, during which there were fewer than 30,000 cervical screening tests carried out. The number of cervical screening tests increased in May and June, with a slight decrease in July and August, before increasing again in September 2020. Even with these differences, the number of cervical screening tests appear to have levelled off in July to September 2020.
While there were fewer cervical screening tests in 2020 compared with 2019, the impact of COVID-19 cannot be quantified without further years of data (as 2020 is the first year impacted by the transition to 5-yearly screening).
Source: Australian Institute of Health and Welfare analysis of National Cancer Screening Register data
Smith, MA, Gertig, D, Hall, M, Simms, K, Lew, JB, Malloy, M, Saville, M, & Canfell, K 2016. Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use. BMC health services research, 16, 147.
Bowel cancer screening kits are sent to eligible invitees (those who fall within target age groups between 50 to 74 years) every 2 years. However, due to factors including transport times and weather (which can affect the quality of the sample returned for laboratory testing), there are some fluctuations in the number of screening kits sent out each month. This in turn impacts the number of completed kits that are returned in the ensuing weeks and months. The National Bowel Cancer Screening Program has also broadened its target age groups in recent years, and in early 2020 finalised the process of increasing the frequency of testing. This has led to testing kits being sent to more people in recent years. These factors can make it difficult to assess clear patterns in the number of participants each month, and in particular during the COVID-19 pandemic.
From the data, it appears that the COVID-19 pandemic did not have a direct effect on bowel cancer screening. The number of tests returned was, at times, lower in 2020 than in 2019. However, this does not appear to be related to the COVID-19 pandemic, and there may have been other factors behind this.
The number of kits returned did rise around the time restrictions first started to ease, overtaking the 2019 numbers by the end of June. This may have been due to a greater number of invitations sent in the preceding months. Likewise, a decrease in the number of kits returned in August and may have been due to a drop in the number of invitations sent in June and July.
Given the impact of the first wave on cancer screening in Australia, there is particular interest in understanding if and how screening may have been impacted by the second wave in Victoria.
This section explores monthly cancer screening test data for Victoria only. Various restrictions were introduced in July 2020, with the highest level of restrictions (Melbourne to Stage 4 and regional Victoria to Stage 3) introduced from 2 August 2020.
The number of screening mammograms performed through BreastScreen Victoria dropped in March and April 2020 in line with tightened restrictions on 25 March 2020. The number of screening mammograms increased but remained lower from June to August 2020. In September 2020, the number of screening mammograms performed was similar to the number performed in 2018 (2018 is chosen as the comparison year instead of 2019, as BreastScreen Australia is a biennial program).
The number of cervical screening tests performed was lower in 2020 than 2019 due to a change from 2-yearly screening to 5-yearly screening. In April the number of cervical screening tests performed fell even lower. Numbers rose again in May and June before falling slightly in July and August. The number of cervical screening tests rose slightly again in September 2020.
The number of invitations sent fluctuated considerably, being very low in January, then rising to a peak in May, then decreasing to a low in early July, before rising again. The number of kits returned was lower for each month in 2020 compared with 2019 until May 2020, after which the number of kits returned was higher, possibly due to the earlier peak in invitations. In June and July, there were more kits returned in 2020 than in 2019, and then in August this was reversed, with fewer kits returned in 2020 than in 2019. By the end of September, the number of kits returned in 2020 was similar to the number in 2019.
Notes for the above three figures:
Source: Australian Institute of Health and Welfare analysis of state and territory BreastScreen register data; Australian Institute of Health and Welfare analysis of National Cancer Screening Register data
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.